| Tender Brief | Supply Of Inj Eculizumab 300 Mg,inj Eculizumab 300 Mg,inj Eculizumab 300 Mg,inj Eculizumab 300 Mg,inj Eculizumab 300 Mg,inj Eculizumab 300 Mg,inj Tremelimumab 300 Mg,inj Tremelimumab 300 Mg,inj Tremelimumab 300 Mg,inj Tremelimumab 300 Mg,inj Tremelimumab 300 Mg,inj Tremelimumab 300 Mg,inj Tislelizumab 100 Mg,inj Tislelizumab 100 Mg,inj Tislelizumab 100 Mg,inj Tislelizumab 100 Mg,inj Tislelizumab 100 Mg,inj Tislelizumab 100 Mg,tab Ivosidenib 250 Mg,tab Ivosidenib 250 Mg,tab Ivosidenib 250 Mg,tab Ivosidenib 250 Mg,tab Ivosidenib 250 Mg,tab Ivosidenib 250 Mg,inj Human Insulin Analog Aspart 30 Per 70,inj Human Insulin Analog Aspart 30 Per 70,inj Human Insulin Analog Aspart 30 Per 70,inj Human Insulin Analog Aspart 30 Per 70,inj Human Insulin Analog Aspart 30 Per 70,inj Human Insulin Analog Aspart 30 Per 70,inj Human Growth Hormone 36 Iu, 12 Mg Per Ml,inj Human Growth Hormone 36 Iu, 12 Mg Per Ml,inj Human Growth Hormone 36 Iu, 12 Mg Per Ml,inj Human Growth Hormone 36 Iu, 12 Mg Per Ml,inj Human Growth Hormone 36 Iu, 12 Mg Pe Quantity: 1111 |
|---|
